查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1992541

外科黏合劑市場：2026-2032年全球市場預測（按產品、成分、手術方法、應用和最終用戶分類）

Surgical Adhesives Market by Product, Composition, Surgical Method, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外科黏合劑市場價值將達到 19.2 億美元，到 2026 年將成長到 21 億美元，到 2032 年將達到 37.4 億美元，複合年成長率為 9.96%。

主要市場統計數據
基準年 2025 19.2億美元
預計年份：2026年 21億美元
預測年份：2032年 37.4億美元
複合年成長率 (%) 9.96%

對臨床需求、外科技術變革和營運限制如何重塑現代外科醫學中組織黏合劑的優先事項進行策略概述。

在外科黏合劑領域，臨床創新、監管完善和醫療服務管道的演變等關鍵因素相互交織，重新定義了現代外科手術中組織通路建立和止血的方式。過去十年，在微創手術的興起、人們對手術效果期望的不斷提高以及對手術全期資源成本效益的日益重視的推動下，黏合劑技術已從一種輔助工具發展成為外科手術工具包的核心組成部分。因此，從研發人員和契約製造到醫院採購團隊和臨床醫生，整個價值鏈上的相關人員正在重新評估產品系列、供應模式以及推廣應用所需的實證依據。

微創手術、生物材料的突破、不斷變化的監管要求以及供應鏈的重組，是如何全面重塑外科黏合劑市場的？

多項變革性轉變正在加速整個外科黏合劑生態系統的變革，每一項都重塑了產品開發的重點和商業化路徑。首先，微創手術的持續發展增加了對適用於內視鏡給藥、快速聚合以及減少熱損傷和機械損傷的黏合劑的需求，從而凸顯了可透過狹窄管腔和鉸接式器械進行應用的材料科學創新。其次，隨著對品質指標和基於價值的採購方式的日益重視，醫療系統要求提供強力的臨床證據，證明使用黏合劑能夠帶來可衡量的結果，例如降低滲漏率、縮短手術時間和降低再入院風險。

關稅和貿易政策的不確定性所帶來的成本壓力如何推動外科黏合劑鏈的韌性、供應商多元化以及生產地點的重新評估？

隨著製造商和醫療保健系統評估關稅措施對原料採購、定價策略和供應商選擇的間接影響，貿易政策與可預測供應鏈之間的相互作用變得日益重要。在關稅措施集中的地區，企業反映原物料和零件成本面臨上漲壓力，波及採購談判和庫存計畫決策。為此，許多企業優先考慮供應商多元化、儲備關鍵材料以及與物流合作夥伴密切合作，以降低關稅波動帶來的風險。

精準的市場區隔洞察，揭示產品類型、成分、手術方法、應用和最終用戶趨勢的交會點，從而形成競爭優勢。

深入的細分市場分析揭示了外科黏合劑領域創新與需求的交匯點，而這種細緻的分析對於確定研發和商業化舉措的優先順序至關重要。從產品類型來看，膠原蛋白基黏合劑、氰基丙烯酸酯基黏合劑、纖維蛋白膠、親水膠體基黏合劑和矽酮基黏合劑各自具有不同的性能特徵和臨床應用場景。有些技術適用於快速止血，而有些技術則提供持續的組織滲透性和良好的皮膚相容性。這種產品層面的差異與生物來源黏合劑和合成黏合劑之間的成分差異密切相關。生物來源配方通常優先考慮生物相容性和吸收性，而合成替代品則傾向於調節機械性能和儲存穩定性。

美洲、歐洲、中東和非洲以及亞太地區等不同區域的實施模式和監管趨勢存在差異，這影響著市場進入和業務擴大策略。

細微的區域差異導致需求模式、技術採納率和監管合規策略各不相同，企業在規劃市場進入和擴張時必須仔細考慮這些因素。在美洲，完善的醫院網路和許多先進的外科中心為實證黏合劑和新型給藥系統的快速推廣創造了有利環境，但採購流程高度分散且對價格敏感。在歐洲、中東和非洲，管理體制和臨床實踐各不相同。歐洲主要醫療保健系統通常要求提供嚴格的臨床數據和正式的醫療技術評估，而該地區的其他市場可能更注重產品的可近性和可負擔性，從而導致不同的商業性策略。

為什麼臨床療效證明、生產規模、策略夥伴關係和上市後證據生成是外科黏合劑競爭的決定性因素？

在外科黏合劑領域，競爭地位越來越取決於科學差異化、生產能力以及展現顯著臨床效益的能力。那些強調經臨床檢驗的產品特性（例如在潮濕環境下快速密封、降低發炎反應或與微創給藥方式相容）的公司，往往能獲得三級醫療機構早期用戶的更強勁支持。同時，在生產和分銷方面實現規模經濟仍然至關重要，這有助於在價格敏感的分銷管道中保持競爭力，並支持全球範圍內的監管申報。

領導者應實施的策略重點是加強創新管道、鞏固供應鏈、加速臨床應用以及使商業模式適應以金額為準融資。

尋求永續價值的產業領導者應採取多管齊下的策略，將產品創新、業務永續營運和強力的臨床證據相結合。首先，他們應優先投資研發能夠滿足尚未滿足的臨床需求的配方（特別是專為微創給藥和傳統封閉方式難以應用的解剖部位設計的黏合劑），同時考慮採用模組化產品組合策略，平衡生物和合成平台。其次，他們應透過關鍵原料的雙重採購、生產能力的選擇性地域分配以及確保在貿易和物流中斷期間柔軟性的合約條款，來增強供應鏈的韌性。

為了支持我們的結論和建議，我們採用了嚴格的混合方法研究框架，結合了對臨床醫生的訪談、採購見解、監管審查和三角驗證的二手證據。

本分析整合了主要調查和次要調查的調查方法，以確保對實證建議和研究結果進行嚴格檢驗。主要調查包括對專科臨床醫生、醫院系統和門診手術中心的採購經理、製造專家以及監管事務專家進行的結構化訪談。這些訪談提供了對採納促進因素、流程和採購挑戰的定性理解，並透過專家諮詢會議檢驗了解釋的有效性，隨後對策略影響進行了壓力測試。

簡要概述決定哪些外科黏合劑技術能夠實現持續臨床應用和商業性成功的策略挑戰。

總而言之，外科黏合劑產業正處於一個轉折點，需要將材料創新、手術流程改進和商業策略緊密結合，才能創造臨床和經濟價值。能夠滿足微創手術技術要求、在各種臨床環境中提供可重複性能，並擁有可靠的真實世界數據支援的黏合劑技術，對於優先考慮療效和效率的醫療系統而言，最具吸引力。同時，能夠透過供應鏈的靈活性和精心製定的區域打入市場策略，確保供應連續性並滿足區域監管要求的公司，將能夠在競爭中脫穎而出。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 外科黏合劑市場：依產品分類

  • 膠原蛋白黏合劑
  • 氰基丙烯酸黏合劑
  • 纖維蛋白膠
  • 親水膠體黏合劑
  • 矽基黏合劑

第9章 外科黏合劑市場：依成分分類

  • 生物基黏合劑
  • 合成黏合劑

第10章 外科黏合劑市場：依手術方法分類

  • 微創手術
  • 開放性手術

第11章黏合劑市場：按應用領域分類

  • 心血管外科
  • 整形手術
  • 一般外科
  • 整形外科手術

第12章 外科黏合劑市場：依最終用戶分類

  • 門診手術中心
  • 醫院和診所
  • 專業醫療中心

第13章 外科黏合劑市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章黏合劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 外科黏合劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國外科黏合劑市場

第17章：中國外科黏合劑市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Advanced Medical Solutions Group PLC
  • Artivion, Inc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson, and Company
  • Cardinal Health, Inc.
  • Chemence Medical, Inc.
  • Connexicon Medical Limited
  • CSL Behring AG
  • GEM Srl
  • GluStitch Inc.
  • Grena Ltd.
  • HB Fuller Company
  • Henkel AG & Co. KGaA
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Kuraray America, Inc.
  • Medline Industries, LP
  • Medtronic PLC
  • Meyer-Haake GmbH Medical Innovations
  • Mitsui Chemicals, Inc.
  • Nordson Corporation
  • Sealantis Ltd.
  • UFP Technologies Inc.
  • Vivostat A/S
Product Code: MRR-5456033C8C0A

The Surgical Adhesives Market was valued at USD 1.92 billion in 2025 and is projected to grow to USD 2.10 billion in 2026, with a CAGR of 9.96%, reaching USD 3.74 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.92 billion
Estimated Year [2026] USD 2.10 billion
Forecast Year [2032] USD 3.74 billion
CAGR (%) 9.96%

A strategic overview of how clinical demands, procedural shifts, and operational constraints are reshaping priorities for tissue adhesives across contemporary surgical practice

The surgical adhesives landscape is experiencing a pivotal convergence of clinical innovation, regulatory refinement, and shifting care delivery pathways that together are redefining how tissue approximation and hemostasis are achieved in modern surgery. Over the past decade, adhesive technologies have evolved from niche adjuncts to core components of procedural toolkits, driven by the push toward less invasive interventions, heightened expectations for surgical outcomes, and a growing emphasis on cost-effective perioperative resource utilization. Consequently, stakeholders across the value chain-from developers and contract manufacturers to hospital procurement teams and clinicians-are reassessing product portfolios, supply models, and the evidence base required for adoption.

This report begins by framing the clinical imperatives that are influencing adhesive selection, including surgeon preference patterns, patient safety priorities, and the increasing demand for adhesives that deliver reliable sealing with minimal tissue reaction. It then situates those imperatives within operational realities such as sterilization standards, packaging innovation, and inventory management pressures in high-throughput settings. By connecting clinical need to commercial strategy, the introduction clarifies why adhesives that balance performance, ease of use, and regulatory compliance are positioned to win in environments where productivity and outcomes are both scrutinized. As a result, leaders must integrate clinical validation, manufacturing resilience, and payer considerations into their product development and go-to-market roadmaps.

How minimally invasive procedures, biomaterials breakthroughs, evolving regulatory expectations, and supply chain reconfiguration are collectively redefining the surgical adhesives landscape

Several transformative shifts are accelerating change across the surgical adhesives ecosystem, each reshaping product development priorities and commercial pathways. First, the persistent migration toward minimally invasive surgery is amplifying demand for adhesives optimized for endoscopic delivery, rapid polymerization, and reduced thermal or mechanical trauma, thereby privileging materials science innovations that can be deployed through narrow lumens and articulated instruments. Second, an expanding emphasis on quality metrics and value-based procurement is compelling health systems to demand robust clinical evidence that links adhesive use to measurable outcomes such as reduced leak rates, shorter procedure times, or lower readmission risks.

Concurrently, advances in biomaterials are creating new classes of adhesives that combine bioresorbability with targeted adhesion profiles, enabling tissue-specific solutions for cardiovascular, orthopedic, and dermal applications. Regulatory pathways have also matured, with authorities signaling clearer expectations for clinical data and manufacturing controls, which affects time-to-market and commercialization strategy. Finally, global supply chain complexities and evolving procurement practices are prompting companies to pursue strategic partnerships, local manufacturing capabilities, and integrated service offerings that help customers manage cost and continuity of supply. Taken together, these shifts emphasize the need for cross-functional alignment between R&D, regulatory, and commercial teams to convert scientific progress into sustained market access and clinical adoption.

How tariff-induced cost pressures and trade policy uncertainty are driving supply chain resilience, supplier diversification, and production footprint reassessment across surgical adhesive supply chains

The interplay between trade policy and predictable supply chains has taken on renewed importance as manufacturers and health systems evaluate the indirect effects of tariff actions on input sourcing, pricing strategy, and supplier selection. In jurisdictions where tariff measures have been concentrated, companies have reported upward pressure on raw material and component costs, which has cascaded into procurement negotiations and inventory planning decisions. In response, many organizations have prioritized supplier diversification, stockpiling of critical inputs, and closer collaboration with logistics partners to mitigate exposure to tariff-induced volatility.

Beyond immediate cost implications, tariff dynamics influence strategic choices about production footprint and nearshoring. Firms seeking tariff resilience are weighing the trade-offs of localized manufacturing capacity versus the capital intensity of facility establishment. At the same time, procurement teams are re-evaluating long-term contracts to introduce greater flexibility for renegotiation or indexation to input cost movements. Clinically, the potential for supply interruptions has prompted stronger emphasis on qualifying multiple adhesive formulations and packaging options to ensure continuity of care. Taken together, these adjustments do not merely reflect short-term cost management; they signal a structural reorientation toward greater supply chain agility, contractual sophistication, and scenario planning that together reduce operational risk and preserve access to critical surgical consumables.

Precise segmentation insights that reveal where product type, composition, surgical method, application, and end-user dynamics converge to shape competitive advantage

Insightful segmentation analysis illuminates where innovation and demand intersect within the surgical adhesives arena, and this granularity is essential for prioritizing R&D and commercial initiatives. Across product types, collagen-based adhesives, cyanoacrylate adhesives, fibrin sealants, hydrocolloid adhesives, and silicone adhesives each present distinct performance profiles and clinical use cases, with some technologies better suited to rapid hemostasis while others provide durable tissue approximation or dermal compatibility. This product-level differentiation interacts closely with composition-based distinctions between biological adhesives and synthetic adhesives; biological formulations commonly emphasize biocompatibility and resorbability whereas synthetic alternatives frequently focus on tunable mechanical properties and shelf stability.

The surgical method segmentation-minimally invasive surgery versus open surgery-further shapes design priorities, as instruments and delivery modalities for less invasive approaches demand adhesives with lower viscosity, controlled curing kinetics, and compatibility with endoscopic applicators. Application areas such as cardiovascular surgery, cosmetic surgery, general surgery, and orthopedic surgery impose unique performance constraints and evidence requirements; for instance, cardiovascular use cases place heightened emphasis on hemostatic reliability and thromboresistance while cosmetic procedures prioritize aesthetic outcomes and scar minimization. End-user contexts, including ambulatory surgical centers, hospitals & clinics, and specialty care centers, influence procurement cycles, packaging preferences, and the level of training expected for clinical staff. By synthesizing these segmentation lenses, decision-makers can identify which adhesive technologies warrant prioritized investment based on clinical fit, adoption barriers, and the operational models of target customers.

Regionally differentiated adoption patterns and regulatory dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape tailored market entry and scale strategies

Regional nuances drive differentiated demand patterns, technology adoption rates, and regulatory engagement strategies that companies must navigate when planning market entry and expansion. In the Americas, robust hospital networks and a concentration of advanced surgical centers create a favorable environment for high-evidence adhesives and rapid uptake of novel delivery systems, but procurement processes can be highly decentralized and price-sensitive. Europe, the Middle East & Africa present heterogeneous regulatory regimes and clinical practices; while major European health systems often require rigorous clinical data and formal health technology assessments, other markets in the region may prioritize availability and affordability, creating distinct commercial pathways.

Asia-Pacific markets exhibit dynamic contrasts between advanced tertiary centers that rapidly adopt cutting-edge adhesives and vast community settings where cost and distribution efficiency are paramount. Furthermore, regional manufacturing capabilities and regulatory frameworks influence decisions about local production versus export models, and partnerships with regional distributors remain critical to navigating complex reimbursement and procurement landscapes. Understanding these regional differences enables companies to tailor evidence generation, pricing strategies, and go-to-market models to local expectations while preserving a coherent global product narrative that supports scale and regulatory convergence where possible.

Why clinical validation, manufacturing scale, strategic partnerships, and post-market evidence generation are decisive factors for competitive strength in surgical adhesives

Competitive positioning in the surgical adhesives sector is increasingly defined by the combination of scientific differentiation, manufacturing capability, and the ability to demonstrate meaningful clinical benefit. Organizations that emphasize clinically validated product attributes-such as rapid sealing under wet conditions, reduced inflammatory response, or compatibility with minimally invasive delivery-tend to achieve stronger traction with early adopters in tertiary centers. At the same time, scale advantages in manufacturing and distribution remain important for competing in price-sensitive channels and for supporting global regulatory submissions.

Strategic behaviors observed among leading players include targeted partnerships with clinical research centers to build the evidence base, investments in sterile fill-finish and packaging innovation to improve shelf life and usability, and selective M&A to acquire complementary technologies or expand presence in key therapeutic applications. Companies that combine a disciplined pipeline of differentiated formulations with robust quality systems and demonstrated supply continuity are better positioned to win long-term contracts with large health systems. Finally, firms that invest in clinician education and post-market surveillance generate the real-world data necessary to support product claims and inform iterative improvements, thereby reinforcing both clinical credibility and commercial defensibility.

Actionable strategic priorities for leaders to strengthen innovation pipelines, fortify supply chains, accelerate clinical adoption, and align commercial models with value-based procurement

Industry leaders seeking to capture sustainable value should adopt a multifaceted strategy that aligns product innovation with operational resilience and compelling clinical evidence. First, prioritize R&D investments in formulations that address unmet clinical needs-particularly adhesives engineered for minimally invasive delivery and for anatomies where conventional closure is challenging-while also considering modular portfolio strategies that balance biological and synthetic platforms. Second, enhance supply chain resilience through dual-sourcing of critical inputs, selective regional manufacturing capacity, and contractual clauses that provide flexibility in the event of trade or logistics disruption.

Third, accelerate clinical adoption by investing in high-quality, procedure-specific evidence and by designing training programs that reduce learning curves for surgeons and perioperative staff. Fourth, engage proactively with regulators and payers to shape pathways that recognize outcome-based benefits and to streamline reimbursement discussions. Fifth, adopt pricing and contracting models that reflect total cost of care benefits rather than unit price alone, which can unlock procurement dialogues in value-oriented health systems. Finally, pursue partnerships with device manufacturers, surgical platforms, and distribution networks to expand reach while preserving focus on core technological strengths. These steps collectively enable market leaders to translate scientific advantage into durable commercial outcomes.

A rigorous mixed-methods research framework combining clinician interviews, procurement insights, regulatory review, and triangulated secondary evidence to underpin conclusions and recommendations

This analysis integrates primary and secondary research methods to ensure evidence-based recommendations and rigorous validation of insights. Primary research comprised structured interviews with clinicians across specialties, procurement leaders in hospital systems and ambulatory surgical centers, manufacturing experts, and regulatory affairs professionals. These interviews informed qualitative understanding of adoption drivers, procedural workflows, and procurement sensitivities, and were supplemented by expert advisory sessions to validate interpretation and to stress-test strategic implications.

Secondary research drew on peer-reviewed clinical literature, regulatory guidance documents, product labeling and instructions for use, patent filings, and company disclosures to establish technical context and to confirm material science developments. Data synthesis applied triangulation techniques to reconcile differing inputs and to identify consistent themes across geographies and stakeholder groups. Throughout, emphasis was placed on transparency of assumptions, reproducibility of analytical approaches, and the separation of descriptive findings from strategic interpretation, enabling readers to trace the evidentiary basis for each recommendation and to adapt insights to their organizational context.

A concise synthesis of the strategic imperatives that will determine which surgical adhesive technologies achieve durable clinical adoption and commercial success

In summary, the surgical adhesives sector stands at an inflection point where materials innovation, procedural evolution, and commercial strategy must be tightly aligned to realize clinical and economic value. Adhesive technologies that respond to the technical demands of minimally invasive surgery, that offer reproducible performance in varied clinical settings, and that are supported by robust real-world evidence will be the most compelling to health systems focused on outcomes and efficiency. Concurrently, supply chain agility and thoughtful regional go-to-market approaches will differentiate companies able to ensure continuity of supply and to meet localized regulatory expectations.

As stakeholders navigate these dynamics, success will favor organizations that integrate scientific differentiation with disciplined operations, proactive regulatory engagement, and targeted clinical programs. By focusing on these priorities, industry participants can convert emerging opportunities into sustainable adoption and long-term partnership with the clinical community.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Adhesives Market, by Product

  • 8.1. Collagen-Based Adhesives
  • 8.2. Cyanoacrylate Adhesives
  • 8.3. Fibrin Sealants
  • 8.4. Hydrocolloid Adhesives
  • 8.5. Silicone Adhesives

9. Surgical Adhesives Market, by Composition

  • 9.1. Biological Adhesives
  • 9.2. Synthetic Adhesives

10. Surgical Adhesives Market, by Surgical Method

  • 10.1. Minimally Invasive Surgery
  • 10.2. Open Surgery

11. Surgical Adhesives Market, by Application

  • 11.1. Cardiovascular Surgery
  • 11.2. Cosmetic Surgery
  • 11.3. General Surgery
  • 11.4. Orthopedic Surgery

12. Surgical Adhesives Market, by End-User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals & Clinics
  • 12.3. Specialty Care Centers

13. Surgical Adhesives Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Surgical Adhesives Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Surgical Adhesives Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Surgical Adhesives Market

17. China Surgical Adhesives Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. Advanced Medical Solutions Group PLC
  • 18.7. Artivion, Inc
  • 18.8. B. Braun Melsungen AG
  • 18.9. Baxter International Inc.
  • 18.10. Becton, Dickinson, and Company
  • 18.11. Cardinal Health, Inc.
  • 18.12. Chemence Medical, Inc.
  • 18.13. Connexicon Medical Limited
  • 18.14. CSL Behring AG
  • 18.15. GEM S.r.l.
  • 18.16. GluStitch Inc.
  • 18.17. Grena Ltd.
  • 18.18. H.B. Fuller Company
  • 18.19. Henkel AG & Co. KGaA
  • 18.20. Integra LifeSciences Holdings Corporation
  • 18.21. Johnson & Johnson Services, Inc.
  • 18.22. Kuraray America, Inc.
  • 18.23. Medline Industries, LP
  • 18.24. Medtronic PLC
  • 18.25. Meyer-Haake GmbH Medical Innovations
  • 18.26. Mitsui Chemicals, Inc.
  • 18.27. Nordson Corporation
  • 18.28. Sealantis Ltd.
  • 18.29. UFP Technologies Inc.
  • 18.30. Vivostat A/S

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL ADHESIVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL ADHESIVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COLLAGEN-BASED ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COLLAGEN-BASED ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COLLAGEN-BASED ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COSMETIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COSMETIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 111. GCC SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GCC SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 113. GCC SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 114. GCC SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. GCC SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. GCC SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 129. G7 SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. G7 SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. G7 SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 132. G7 SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 133. G7 SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. G7 SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 135. NATO SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. NATO SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. NATO SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 138. NATO SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 139. NATO SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NATO SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)